Published in Exp Mol Pathol on June 01, 1967
Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand Factors. Proc Natl Acad Sci U S A (1973) 1.27
Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist. Agents Actions (1982) 1.04
Aggregation of human platelets by commercial preparations of bovine and porcine antihaemophilic globulin. J Clin Pathol (1972) 0.89
Glycogen distribution in rat blood platelets. Am J Pathol (1973) 0.78
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med (1999) 4.61
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med (1999) 3.39
In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science (1993) 2.95
Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver. Mol Ther (2000) 2.12
Overdosage of opiate from patient controlled analgesia devices. BMJ (1994) 1.89
Guide to materials for use in teaching clinical nutrition in schools of medicine, dentistry, and public health. Am J Clin Nutr (1983) 1.77
Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther (1998) 1.52
Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci U S A (1985) 1.47
Extradural sufentanil by patient-controlled analgesia or nurse-administered compared with optimal morphine in a high dependency unit: effects on oxygenation and pain relief after abdominal surgery. Br J Anaesth (1994) 1.39
Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease. Proc Natl Acad Sci U S A (1989) 1.35
Morphologic manifestations of blood-solid interfacial reactions. A scanning and transmission electron microscopic study. Lab Invest (1969) 1.34
Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs. Proc Natl Acad Sci U S A (1990) 1.28
United States (US) multi-center study to assess the validity and reliability of the Spinal Cord Independence Measure (SCIM III). Spinal Cord (2011) 1.22
Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs. Gene Ther (1996) 1.12
The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A. Blood (1993) 1.10
Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum Gene Ther (1995) 1.09
Some species differences in fibrinolysis and blood coagulation. J Biomed Mater Res (1971) 1.08
Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Proc Natl Acad Sci U S A (1978) 1.04
Platelet-platelet interaction: relationship to hemostasis and thrombosis. Fed Proc (1967) 1.04
Recombinant human factor IX: replacement therapy, prophylaxis, and pharmacokinetics in canine hemophilia B. Blood (1996) 1.03
Venous thrombosis on prosthetic surfaces. Evolution and blood coagulation studies in a nonhuman primate model. Am J Pathol (1974) 1.03
Venom coagglutinin for detection of von Willebrand factor activity in animal plasmas. J Lab Clin Med (1983) 1.02
Preservation of platelet receptors for platelet aggregating factor/von Willebrand factor by air drying, freezing, or lyophilization: new stable platelet preparations for von Willebrand factor assays. Thromb Res (1978) 1.02
Plasma levels of platelet aggregating factor/vom Willebrand factor in various species. Thromb Res (1977) 1.01
Heparin neutralization of PGI2: effects upon platelets. Science (1979) 1.01
Studies of an activity from endothelial cells that inhibits platelet aggregation, serotonin release, and clot retraction. Thromb Res (1974) 1.01
The endothelium: roles in thrombosis and hemostasis. Arch Pathol Lab Med (1977) 1.00
Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor. Proc Natl Acad Sci U S A (1987) 0.99
The platelet: membrane and surface reactions. Annu Rev Physiol (1976) 0.98
Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill colony. Thromb Haemost (2000) 0.98
Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras. Proc Natl Acad Sci U S A (1995) 0.97
Effects of platelets and certain platelet components on growth of cultured human endothelial cells. Thromb Res (1975) 0.94
Malnutrition, hunger, and behavior. I. Malnutrition and learning. J Am Diet Assoc (1973) 0.94
Use of venom coagglutinin and lyophilized platelets in testing for platelet-aggregating von Willebrand factor. Blood (1980) 0.93
Ultrastructural aspects of interactions of platelets with microcrystalline collagen. Am J Pathol (1976) 0.93
Lyophilized platelets: continued development. Transfus Sci (2000) 0.93
Study of the reactions of blood with artificial surfaces. Use of the thrombogenerator. Lab Invest (1974) 0.92
The interaction of blood hemostitic elements with aritificial surfaces. Prog Hemost Thromb (1972) 0.92
Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotype. Am J Pathol (1992) 0.92
Fibrinogen--its role in platelet agglutination and agglutinate stability. A study of congenital aibrinogenemia. Lab Invest (1966) 0.91
Thrombotic thrombocytopenia with von Willebrand factor deficiency induced by botrocetin. An animal model. Lab Invest (1988) 0.91
Effects of certain purified plasma proteins on the compatibility of glass with blood. Am J Pathol (1973) 0.90
Malnutrition, hunger, and behavior. II. Hunger, school feeding programs, and behavior. J Am Diet Assoc (1973) 0.90
Freeze-etch observations on the plasma membrane and other structures of normal and abnormal platelets. Am J Pathol (1973) 0.89
Sites of acetylation of sickle cell hemoglobin by aspirin. Proc Natl Acad Sci U S A (1974) 0.89
Effects of heparin on platelet aggregation and release and thromboxane A2 production. Am J Pathol (1981) 0.88
Cross-sectional study of nutrition knowledge and attitudes of medical students at three points in their medical training at 11 southeastern medical schools. Am J Clin Nutr (1988) 0.87
Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex. Proc Natl Acad Sci U S A (1983) 0.87
Some effects of a microcrystalline collagen preparation on blood. Haemostasis (1974) 0.87
Unbalanced globin chain synthesis in congenital dyserythropoietic anemia. Blood (1973) 0.87
Apparent similarity of mechanisms of platelet adhesion and aggregation. Differentiation of these functions from clot retraction. Thromb Diath Haemorrh (1972) 0.86
Comparison of certain functions of human platelets separated from blood by various means. Am J Pathol (1974) 0.86
Characterization of human platelets separated from blood by ADP-induced aggregation. Am J Pathol (1975) 0.86
Pathophysiology of platelet-aggregating von Willebrand factor: applications of the venom coagglutinin vWF assay. Ann N Y Acad Sci (1981) 0.85
Inhibition of human platelet-collagen adhesion reaction by amitriptyline and imipramine. Proc Soc Exp Biol Med (1974) 0.85
Multiple active forms of thrombin: binding to platelets and effects on platelet function. Proc Natl Acad Sci U S A (1976) 0.85
von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosis. Arteriosclerosis (1990) 0.85
Sickle cell syndromes. II. The sickle cell anemia-alpha-thalassemia syndrome. J Pediatr (1978) 0.85
Development of coronary atherosclerosis in swine with severe hypercholesterolemia. Lack of influence of von Willebrand factor or acute intimal injury. Arteriosclerosis (1986) 0.85
Perceived risks of radioactive waste transport through Oregon: results of a statewide survey. Risk Anal (1994) 0.85
Platelet ATPase activities. II. ATPase activities of isolate platelet membrane fractions. Am J Pathol (1969) 0.84
Adhesion of human blood platelets to glass and polymer surfaces. I. Studies with platelets in plasma. Haemostasis (1974) 0.84
Interaction of plasma proteins with artificial surfaces: protein adsorption isotherms. J Lab Clin Med (1978) 0.84
Failure to achieve gene conversion with chimeric circular oligonucleotides: potentially misleading PCR artifacts observed. Antisense Nucleic Acid Drug Dev (1998) 0.84
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B. Thromb Haemost (1997) 0.84
Hemoglobin Abraham Lincoln, beta32 (B14) leucine leads to proline. An unstable variant producing severe hemolytic disease. J Clin Invest (1973) 0.84
Determinants of von Willebrand factor activity elicited by ristocetin and botrocetin: studies on a human von Willebrand factor-binding antibody. Semin Thromb Hemost (1985) 0.83
Thrombotic thrombocytopenia induced in dogs and pigs. The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura. Arterioscler Thromb Vasc Biol (1995) 0.82
The adhesion of platelets to subendothelium, collagen and artifilial surfaces. Semin Thromb Hemost (1976) 0.82
von Willebrand factor and animal models: contributions to gene therapy, thrombotic thrombocytopenic purpura, and coronary artery thrombosis. Mayo Clin Proc (1991) 0.82
Heparin potentiates synthesis of thromboxane A2 in human platelets. Adv Prostaglandin Thromboxane Res (1980) 0.82
Adhesion of human blood platelets to glass polymer surfaces. II. Demonstration of the presence of a natural platelet adhesion inhibitor in plasma and serum. Haemostasis (1976) 0.82
Cellular growth, nutrition and development. Pediatrics (1970) 0.82
Platelet retention in particle-filled columns: effects of particle type, plasma proteins, and platelet reactivity. Am J Clin Pathol (1971) 0.82
Acetylcholinesterase, choline acetyltransferase, and the postulated acetylcholine receptor of canine platelets. Biochem Pharmacol (1976) 0.82
Coronary atherosclerosis in the pig. Induced plaque injury and platelet response. Arteriosclerosis (1990) 0.81
Unbalanced globin chain synthesis by Hb Lincoln Park (anti-Lepore) reticulocytes. Am J Hematol (1978) 0.81
Alteration of platelet adhesion to glass in vascular disorders and certain other diseases. Am J Clin Pathol (1972) 0.81
Sickle cell syndromes. I. Hemoglobin SC-alpha-thalassemia. Pediatr Res (1976) 0.81
Reactions of blood with nonbiologic surfaces. Ultrastructural and clotting studies with normal and coagulation factor deficient bloods. Am J Pathol (1972) 0.81
Acetylcholine, cholinesterase activity, and the aggregability of human platelets. Proc Soc Exp Biol Med (1970) 0.81
Platelet ATPase activities. I. Ecto-ATPases of intact platelets and their possible role in aggregation. Am J Pathol (1969) 0.81
Hemoglobin Milledgeville (alpha 44 (CD2) Pro leads to Leu): a new variant with increased oxygen affinity. Biochim Biophys Acta (1980) 0.81
Blood compatibility of biomaterials: evaluation of a simple screening test. Biomater Med Devices Artif Organs (1973) 0.81
Thrombogenicity of some biomedical materials: platelet-interface reactions. J Biomed Mater Res (1969) 0.81
Intratracheal administration of recombinant human factor IX (BeneFix) achieves therapeutic levels in hemophilia B dogs. Thromb Haemost (2001) 0.81
Sickle hemoglobin in combination with HbJBangkok (alphaA2beta56-2gly leads to asp). Blood (1974) 0.81
Intracellular function in rehydrated lyophilized platelets. Br J Haematol (2000) 0.80
Lessons to be learned: a case study approach. 'Spontaneous' intraperitoneal bladder rupture in a psychiatric patient--with diagnostic difficulties. J R Soc Promot Health (2001) 0.80
Some properties of endothelial cells isolated from human umbilical cord vein. Ser Haematol (1973) 0.80
Creation of a regional medical-nutrition education network. Am J Clin Nutr (1989) 0.80
Some methods for in vitro estimation of the blood compatibility of biomaterials. Bull N Y Acad Med (1972) 0.80
Effect of a new antiaggregating chemical on the structure and function of the human platelet. Am J Pathol (1971) 0.80
Von Willebrand syndrome induced by a Bothrops venom factor: bioassay for venom coagglutinin. Proc Natl Acad Sci U S A (1981) 0.80
Regulation of hemoglobin beta-chain synthesis in bone marrow erythroid cells by alpha chains. Proc Natl Acad Sci U S A (1973) 0.80
Panel conference. Blood surface interactions. Trans Am Soc Artif Intern Organs (1980) 0.79